InvestorsHub Logo
Followers 30
Posts 4823
Boards Moderated 0
Alias Born 01/21/2009

Re: None

Wednesday, 11/04/2015 6:19:57 PM

Wednesday, November 04, 2015 6:19:57 PM

Post# of 144815
Tidbit for you all!

http://cfsites1.uts.edu.au/research/strengths/ht/detail.cfm?ProjectId=2014000473


Projects
Phase 1 - Pharmacyte Biotech Inc research using Melligen Cells

Project Member(s):
Simpson, A.M.

Funding or Partner Organisation:
Pharmacyte Biotech Inc

Completion year:
2016

Summary:
This is a first phase engagement with Pharmacyte Biotech Inc (a US based cell therapy company formerly known as Nuvilex) around investigating the in vitro and in vivo performance of UTS technology (Melligen Cells for diabetes treatment) once encapsulated. Future phases may result in more detailed in vitro and in vivo studies investigating the encapsulated Melligen cells.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News